Ruthenium Bromatum
Generic Name: ruthenium bromatum
Brand Names:
Ruthenium Bromatum
Related Medications
Tralokinumab-ldrm
tralokinumab-ldrm
Interleukin-13 Antagonist [EPC]
11 DESCRIPTION Tralokinumab-ldrm, an interleukin-13 antagonist, is a human IgG4 monoclonal antibody. Tralokinumab-ldrm is produced in mouse myeloma cells by recombinant DNA technology, consists of 1326 amino acids, and has a molecular weight of approximately 147 kilodaltons.
Dog Epithelia
dog epithelia
Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: CANIS LUPUS FAMILIARIS SKIN (10000 [PNU]/mL). Category: BLA.
Antigingivitis/antiplaque Mouth Rinse
antigingivitis/antiplaque mouth rinse
Purpose Antigingivitis/Antiplaque
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.